Counterfeit and substandard quality of drugs: The need for an effective and stringent regulatory control in India and other developing countries

Indian Journal of Pharmacology

Volumn 39, Issue 4, 2007, Pages 206-207

  Khan, Azhar ^a   Ghilzai, Naushad ^b  

^a HAMDARD UNIVERSITY   (India)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; GENERIC DRUG; TUBERCULOSTATIC AGENT; VACCINE;

ARTICLE; DEVELOPING COUNTRY; DRUG CONTROL; DRUG COST; DRUG INDUSTRY; DRUG LABELING; DRUG MARKETING; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; DRUG TREATMENT FAILURE; GOVERNMENT REGULATION; INDIA; LAW ENFORCEMENT; MEDICOLEGAL ASPECT; PHYSICAL CHEMISTRY; QUALITY CONTROL; STANDARD; WORLD HEALTH ORGANIZATION;

EID: 35549003151     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.36541     Document Type: Article

References (20)

1. Charatan F. Fake prescription drugs are flooding the United States. BMJ 2001;322:1443.
2. Schofield J. Counterfeit pharmaceuticals flood Russian market. BMJ 2001;322:1564.
3. Wechsler J. Counterfeiting, compliance and control. Pharm Tech 2003;Vol no missing:28-36.
4. Menkes DB. Hazardous drugs in developing countries. BMJ 1997;315:1557-8.
5. Taylor RB, Shakoor O, Behrens RH. Drug quality, a contributor to drug resistance? Lancet 1995;346:122.
6. Costello AM, Bhutta TI. Antidiarrhoeal drugs for acute diarrhoea in children: None work and many may be dangerous. BMJ 1992;304:1-2.
7. English M, Marsh V, Amukoye E, Lowe B, Murphy S, Marsh K. Chronic salicylate poisoning and severe malaria. Lancet 1996;347:1736-7.
8. Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 2001;357:1933-6.
9. Fleck F. WHO pulls two generic AIDS drugs from approved list. BMJ 2004;328:1518.
10. Odeniyl MA, Adegoke OA, Adereti RB, Odeku OA, Itiola OA. Comparative analysis of eight brands of sulfadoxine-pyrimethamine tablets. Trop J Pharm Res 2003;2:161-7.
11. Newton PN, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et al. Fake artesunate in southeast Asia. Lancet 2001;357:1948 50.
12. Pincock S. WHO tries to tackle problem of counterfeit medicines in Asia. BMJ 2003;327:1126.
13. Guidelines for the development of measures to combat counterfeit drugs. WHO: Geneva, Switzerland; 1999.
14. Parry J. WHO combats counterfeit malaria drugs in Asia. BMJ 2005;330:1044.
15. Report of pre eleventh ICDRA satellite workshop on counterfeit drugs, 13 and 14 February 2004, Madrid, Spain.
16. Burns W. WHO launches taskforce to fight counterfeit drugs. Bull World Health Organ 2006;84:689-90.
17. A study on availability and prices of medicines in India. National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers, Govt. of India. 2002. [Last accessed on 2006 Dec 31]. Available from: http://nppaindia.nic/report/voicerep.html.
18. Mashelkar Committee Report. Ministry of Health and Family Welfare, Government of India. August 2003.
19. Mudur G. India to introduce death penalty for peddling fake drugs. BMJ 2003;327:414.
20. List of Approved Post Graduate Education and Research institutions. All India Council of Technical Education, Govt. of India. September 2004. [Last accessed on 2006 Dec 31]. Available from: http://www.aicte.ernet.in/ApprovInst/ pg_pharm.doc.